John Johnston
Patrimonio netto: 207 104 $ in data 31/05/2026
Patrimonio netto: 207 104 $ in data 31/05/2026
Mr. John J.
Johnston is an Independent Non-Executive Director at MaxCyte, Inc. He is on the Board of Directors at MaxCyte, Inc. Mr. Johnston was previously employed as an Independent Non-Executive Chairman by Constellation Healthcare Technologies, Inc., an Independent Non-Executive Director by Midatech Pharma Plc, an Independent Non-Executive Director by Action Hotels Plc, a Non-Executive Chairman by Flowgroup Plc, a Head-Sales by Nomura Code Securities Ltd., a Non-Executive Director by Revera Asset Management Ltd., a Director-Small Companies Technology by Legg Mason, Inc., and a Head-Small Companies by Scottish Amicable Plc.
He also served on the board at Seymour Pierce Ltd. He received his undergraduate degree from the University of Abertay and an MBA from the University Of Dundee.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
MAXCYTE, INC. 0,16% | 21/04/2026 | 171.160 ( 0,16% ) | 207 104 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MAXCYTE, INC. | Direttore/Membro del Consiglio | 01/01/2016 |
| Società | Posizione | Fine |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Direttore/Membro del Consiglio | 26/02/2019 |
| ACTION HOTELS PLC | Direttore/Membro del Consiglio | 01/12/2018 |
| FLOWGROUP PLC | Presidente | 26/10/2017 |
| CONSTELLATION HEALTHCARE TECH INC | Presidente | 30/01/2017 |
Nomura Code Securities Ltd.
Nomura Code Securities Ltd. Investment ManagersFinance Provides advisory, fundraising, and broking services | Vendite Istituzionali | 01/03/2013 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Legg Mason, Inc.
Legg Mason, Inc. Investment ManagersFinance Provides investment and asset management services | Finance |
MaxCyte, Inc.
MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Seymour Pierce Ltd.
Seymour Pierce Ltd. Investment Banks/BrokersFinance Provides corporate brokerage and finance services | Finance |
Flowgroup Plc
Flowgroup Plc Electric UtilitiesUtilities Focuses on the commercialization of intellectual property and technical product development of alternative energy products | Utilities |
Constellation Healthcare Technologies, Inc.
Constellation Healthcare Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides holistic, integrated suite of practice management support services | Commercial Services |
Scottish Amicable Plc
Scottish Amicable Plc Regional BanksFinance Provides financial and commercial services | Finance |
University Of Dundee
University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revera Asset Management Ltd.
Revera Asset Management Ltd. Investment ManagersFinance Revera is a fundamental investor that uses bottom-up analytical skills to identify businesses where the long-term value of future cash flows is not fully recognized by investors. The firm’s approach also takes account the strategic, operational, financial or macroeconomic risks attached to achieving their goals. They focus exclusively on UK equities, using their experience to build portfolios designed to offer attractive returns over the medium term. | Finance |
Nomura Code Securities Ltd.
Nomura Code Securities Ltd. Investment ManagersFinance Provides advisory, fundraising, and broking services | Finance |
University of Abertay
University of Abertay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Action Hotels Plc
Action Hotels Plc Hotels/Resorts/Cruise linesConsumer Services Owns and operates hotels | Consumer Services |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale